These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 670358
1. [Determination of "middle molecules" presenting vitamin B12 molecular size in normal and uremic body fluids (author's transl)]. Cueille G. J Chromatogr; 1978 Jul 01; 146(1):55-65. PubMed ID: 670358 [Abstract] [Full Text] [Related]
2. Determination of endogenous middle molecules in normal and uremic body fluids. Fürst P, Zimmerman L, Bergström J. Clin Nephrol; 1976 Apr 01; 3(2):178-88. PubMed ID: 1277595 [Abstract] [Full Text] [Related]
3. Technical aspects on middle molecules: separation, isolation, and identification. Cueille G, Man NK, Sausse A, Farges JP, Funck-Brentano JL. Artif Organs; 1981 Apr 01; 4 Suppl():8-12. PubMed ID: 7295100 [Abstract] [Full Text] [Related]
4. Separation of six uremic middle molecular compounds by high performance liquid chromatography and analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Chu J, Yuan Z, Liu X, Wu Q, Mi H, He B. Clin Chim Acta; 2001 Sep 25; 311(2):95-107. PubMed ID: 11566169 [Abstract] [Full Text] [Related]
5. The effect of hemodialysis on endogenous middle molecules in uremic patients. Asaba H, Fürst P, Oulés R, Yahiel V, Zimmerman L, Bergström J. Clin Nephrol; 1979 May 25; 11(5):257-66. PubMed ID: 455822 [Abstract] [Full Text] [Related]
6. Chemical analytic approaches to the definition of uremic toxins. Furst P, Bergstrom J, Gordon A, Zimmermann L. Ateneo Parmense Acta Biomed; 1975 May 25; 46(5):307-16. PubMed ID: 1232992 [Abstract] [Full Text] [Related]
7. Improved separation and quantification of the "middle molecule" b4-2 in uremia. Faguer P, Man NK, Cueille G, Di Giulio S, Funck-Brentano JL. Clin Chem; 1983 Apr 25; 29(4):703-7. PubMed ID: 6831703 [Abstract] [Full Text] [Related]
8. Middle molecules in uremic serum, urine and dialysis fluid. Migone L, Dall'taglio P, Buzio C. Clin Nephrol; 1975 Apr 25; 3(3):82-93. PubMed ID: 1139803 [Abstract] [Full Text] [Related]
14. New dialysis membrane for removal of middle molecule uremic toxins. Yamashita AC. Am J Kidney Dis; 2001 Oct 25; 38(4 Suppl 1):S217-9. PubMed ID: 11576959 [Abstract] [Full Text] [Related]
15. Characterization of a 1100-1300 MW uremic neurotoxin. Funck-Brentano JL, Man NK, Sausse A, Zingraff J, Boudet J, Becker A, Cueille GF. Trans Am Soc Artif Intern Organs; 1976 Oct 25; 22():163-7. PubMed ID: 951836 [No Abstract] [Full Text] [Related]
16. Isolation of inhibitors of ligand: albumin-binding from uremic body fluids and normal urine. Gulyassy PF, Bottini AT, Jarrard EA, Stanfel LA. Kidney Int Suppl; 1983 Dec 25; 16():S238-42. PubMed ID: 6588258 [Abstract] [Full Text] [Related]
17. Isotachophoretic separation of middle molecule peptides in uremic body fluids. Zimmerman L, Baldesten A, Bergström J, Fürst P. Clin Nephrol; 1980 Apr 25; 13(4):183-8. PubMed ID: 7379369 [Abstract] [Full Text] [Related]
18. Middle molecules in uraemia. Fürst P, Asaba M, Gordon A, Zimmerman L, Bergström J. Proc Eur Dial Transplant Assoc; 1975 Apr 25; 11():417-26. PubMed ID: 1105558 [No Abstract] [Full Text] [Related]